[March 05, 2015]

Research and Markets: Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success

Research and Markets (http://www.researchandmarkets.com/research/qglqhh/mature_biotech) has announced the addition of the "Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success" report to their offering.

All biotech companies - Gilead (GILD), Amgen (AMGN), Biogen Idec (BIIB) and Celgene (CELG), in past year, have given a positive return and hence increased the interest of biotech investors. These companies have been able to select therapy/niche indication where the high treatment cost justifies the need. While large pharma companies are active in M&A deals, the Mature biotech companies are sticking to its core expertise and venturing into unexplored/new therapy; e.g., GILD in anti-cancer and BIIB for hemophilia. Alike small molecule generics, biosimilar will also get easier and getting smilar pace of recognition in coming years; where AMGN, BIIB already started investing in this space and can emerge as a big player in coming years.

REGN, ALXN, and VRTX have transformed into a large-cap mature biotech companies. Whether these three will be acquired or will remain independent and evolve in next giant is still a question, but both the cases present a good investment opportunity for those who willing to hold them for next five years.

GILD has announced the dividend payment and now all eyes will be on CELG and BIIB

Key Topics Covered:

1. Acorda Therapeutics - Neurological Pipeline Getting Bigger

2. Alexion Pharma - Pipeline Maturity will witness a Strong 2015 for ALXN

3. Amgen - Focus On New Biologics For Larger Market And Exploiting Biologics' Manufacturing Experience For Biosimilars Gain

4. Biogen Idec - Growth from Newly Launched Products + Clinical Milestones of Novel Pipeline

5. Celgene - Innovative Strategies for Long Term Gains

6. Gilead Sciences - Poised to Emerge as a Leader in HCV Treatment

7. Regeneron - Late-Stage Pipeline Potential - Accelerator for Further Growth

8. Vertex Pharma - From Large Volume Market to Niche Indications - Transformation has Paid (News - Alert)

Companies Mentioned

- ACOR

- ALXN

- AMGN

- Acorda

- Alexion

- Amgen

- BIIB

- Biogen Idec

- CELG

- Celgene

- GILD

- Gilead

- REGN

- Regeneron

- VRTX

- Vertex (News - Alert)

For more information visit http://www.researchandmarkets.com/research/qglqhh/mature_biotech

[ Back To TMCnet.com's Homepage ]